Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer Post published:April 1, 2021 Post category:Press Release
Lobe Sciences Becomes Enterprise Member of NFL Alumni Association Post published:March 31, 2021 Post category:Press Release
Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement Post published:March 31, 2021 Post category:Press Release
MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients Post published:March 31, 2021 Post category:Press Release
Nova Mentis Establishes Serotonin Research Centre Post published:March 31, 2021 Post category:Press Release
Psyence Group and Pure Extracts Sign JV Letter of Intent for the Extraction of Psilocybin from Psychedelic Mushrooms and Development of Psilocybin Formulations Post published:March 31, 2021 Post category:Press Release
MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS Post published:March 30, 2021 Post category:Press Release
Noetic Launches Venture Studio to Build Psychedelic Biotechnology Companies Post published:March 30, 2021 Post category:Press Release
Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe Post published:March 30, 2021 Post category:Press Release
Silo Wellness Hires Two Veterans of Lifestyle Marketing and Cannabis Industry to Promote Marley Line of Functional & Psychedelic Mushroom Brand Post published:March 30, 2021 Post category:Press Release